852203-01-1

Upstream product

• 89001-53-6 2-cyano-5-nitrotoluene 

Downstream Products

• 915034-90-1 4-nitro-2-phenoxymethyl-benzonitrile 
• 1228773-18-9 tert-butyl N-[(2-cyano-5-nitrophenyl)methyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate 
• 915034-91-2 4-nitro-2-(phenoxymethyl)benzoic acid 
• 1264926-61-5 C₂₉H₃₃N₅O₅ 
• 1264926-59-1 C₃₄H₄₁N₅O₇ 
• 1264926-53-5 C₁₈H₂₄ClN₃O₄ 
• 1264926-51-3 C₁₈H₂₄ClN₃O₄ 
• 1264924-47-1 4-[(2,3-dihydro-1-imino-1H-isoindol-5-yl)amino]-6-(4-methylphenyl)-5-pyrimidinol 
• 1264924-50-6 2,3-dihydro-1-imino-N-[5-methoxy-6-(4-methylphenyl)-4-pyrimidinyl]-1H-isoindol-5-amine 
• 1264926-49-9 C₃₀H₃₅N₅O₅ 
• 1228773-19-0 tert-butyl N-[(5-amino-2-cyanophenyl)methyl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate 

Relevant academic research and scientific papers

4, 5, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES AS FACTOR IXA INHIBITORS

The present invention relates to novel heterocyclic compounds of Formulae (I): (Chemical formula should be inserted here as it appears on abstract in paper form) Formula (I) as disclosed herein, or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder.

DIBENZOCYCLOHEPTANE COMPOUNDS AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS

The present invention relates to compounds of formula (I), in which R1, R2, R3, R4, X and Y have the meanings indicated in the description. These compounds have immuno-modulating effects, as well as an inhibiting or regulating effect on the release of IL-1β and/or TNF-α. They can therefore be used for the treatment of diseases associated with a disturbance of the immune system.

TETRACYCLIC SULFONAMIDE COMPOUNDS AND METHODS OF USE THEREOF

The present invention relates to Tetracyclic Sulfonamide Compounds, compositions comprising an effective amount of a Tetracyclic Sulfonamide Compound and methods for treating or preventing an inflammatory disease, a reperfusion injury, diabetes, a diabetic complication, reoxygenation injury resulting from organ transplantation, an ischemic condition, Parkinson's disease, renal failure, a vascular disease, a cardiovascular disease, or cancer, comprising administering to a subject in need thereof an effective amount of a Tetracyclic Sulfonamide Compound.

Methods for treating or preventing erectile dysfunction or urinary incontinence

The present invention relates to methods for treating or preventing erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of a compound of the invention.

Facile and convenient syntheses of 6,11-dihydro-5H-indeno[1,2-c] isoquinolin-5-ones and 6,11-dihydro-5H-indolo[3,2-c]isoquinolin-5-one

(Chemical Equation Presented) The synthesis of 6,11-dihydro-5H-indeno[1,2- c]isoquinolin-5-ones from the base-promoted condensation reaction of homophthalic anhydride and 2-(bromomethyl)-benzonitrile and a convenient method for the synthesis of indolo[3,2-c]isoquinolinones are described.